Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
18 Leser
Artikel bewerten:
(0)

Regenerative Medicine - Global Strategic Business Report 2014

DUBLIN, Sept. 10, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Regenerative Medicine - Global Strategic Business Report" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 46 companies including many key and niche players such as:

  • AlloSource
  • Anika Therapeutics, Inc.
  • Biomet, Inc.
  • Bioventus LLC
  • DePuy Synthes Companies

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY
1. OUTLOOK
2. REGENERATIVE MEDICINE A MACRO PERSPECTIVE
3. BONE AND JOINT REGENERATIVE MEDICINE AN OVERVIEW
4. COMPETITIVE LANDSCAPE
5. REGENERATIVE MEDICINE IN OTHER AREAS
6. REGULATORY ENVIRONMENT
7. A PEEK INTO THE GLOBAL ORTHOPEDIC INDUSTRY
8. RESEARCH AND DEVELOPMENT
9. PRODUCT OVERVIEW
10. PRODUCT INNOVATIONS/INTRODUCTIONS
11. RECENT INDUSTRY ACTIVITY
12. FOCUS ON SELECT PLAYERS

  • AlloSource (US)
  • Anika Therapeutics, Inc. (US)
  • Biomet, Inc. (US)
  • Bioventus LLC (US)
  • DePuy Synthes Companies (US)
  • DePuy Spine, Inc. (US)
  • Exactech, Inc. (US)
  • Histogenics Corp. (US)
  • Integra LifeSciences Holdings Corp (US)
  • LifeCell Corporation (US)
  • LifeNet Health, Inc. (US)
  • Medtronic, Inc. (US)
  • NovaBone Products LLC (US)
  • NuVasive, Inc. (US)
  • Orthofix International N.V. (Netherlands)
  • Osiris Therapeutics, Inc. (US)
  • Smith & Nephew Plc (UK)
  • Stryker Corporation (US)
  • TiGenix N.V. (Belgium)
  • Wright Medical Technology, Inc. (US)
  • BioMimetic Therapeutics LLC (US)
  • Zimmer Holdings, Inc. (US)

13. GLOBAL MARKET PERSPECTIVE

III. MARKET
1. THE UNITED STATES
2. JAPAN
3. EUROPE
4. ASIA-PACIFIC
5. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 46 (including Divisions/Subsidiaries 51)

  • The United States (38)
  • Europe (11)
  • Germany (2)
  • The United Kingdom (2)
  • Rest of Europe (7)
  • Asia-Pacific (Excluding Japan) (1)
  • Africa (1)

For more information visit http://www.researchandmarkets.com/research/b3pgkv/regenerative

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.